Introduction
both, accumulation of endothelium-derived kinins and the inhibition of ANG II [13, 14] .
Angiotensin converting enzyme (ACE) is a transmem-
The separate effects of ACE, kinins as well as NO on brane zinc metallopeptidase that cleaves carboxy-terminal the cardiovascular system have been thoroughly investidipeptides from several peptides and is expressed in great gated and described. Since only a small amount of amounts in vascular endothelial cells [1, 2] . A soluble form information is available concerning the physiological / of the enzyme is found in plasma which is presumably pathophysiological significance of their mutual influence derived from the membrane-bound form by proteolytic upon one another this review focuses on recent data cleavage [3] . ACE plays a major role in the regulation of dealing with the interaction of ACE expression / activity, the vascular tone by converting the biological inactive kinins and NO formation / degradation. decapeptide angiotensin I (ANG I) into the vasoconstrictor and proliferative octapeptide angiotensin II (ANG II). In a similar manner, ACE inactivates the vasodilatory nonapep-2. Molecular and biochemical pathways tide bradykinin (BK), which derives from a number of different sources [4] .
Modulation of ACE by NO Endothelium-derived or exogenously added BK exerts its vasodilatory action through stimulation of endothelial
Regulation of ACE expression / activity by NO was B kinin receptors thereby causing the synthesis and reported by several investigators. Chronic inhibition of 2 release of vasodilator substances such as endotheliumendothelial NO synthase (eNOS) led to an upregulation of derived hyperpolarizing factor (EDHF) [5] , prostacyclin cardiac and vascular ACE activity [15, 16] . Furthermore, and nitric oxide (NO) [6] . Many of the effects of NO on removal of endothelium from rat aortae increased ACE platelets [7] , smooth muscle cells [8] , and cardiac activity in these arteries, possibly due to the presence of myocytes [9, 10] are mediated by activation of soluble ACE in the adventitia and in the vascular smooth muscle guanylyl cyclase to synthesize cyclic GMP. The biological layer [2] . In contrast, it was demonstrated that enhanced function of soluble guanylyl cyclase and NO / cyclic GMP NO or NO releasing compounds were capable of inhibiting in endothelial cells is not yet completely understood. One the activity of purified ACE in a concentration-dependent function of endothelial cyclic GMP may be a negative and competitive manner, and that stimulated endothelial feed-back mechanism to turn off further NO synthesis NO release from rat carotid arteries physiologically re- [11, 12] . Changes in the synthesis of ACE, BK and NO are duced conversion of ANG I to ANG II [17] . This inverse associated with a number of cardiovascular conditions relationship between ACE expression / activity and the NO including hypertension, atherosclerosis or coronary heart system was also found in hypertensive rats after long-term disease. ACE inhibitors are able to treat these diseases by ACE inhibition, where inhibited vascular and cardiac ACE expression and activity was associated with an upregulated eNOS expression and increased vascular NO release [18, 19] . Taken together, these observations provided evidence for a 'cross talk' between eNOS expression / activity and tissue ACE expression / activity by means of a feedback regulation. Surprisingly, in cultured human endothelial cells enhancement of cyclic GMP formation by atrial natriuretic factor, phosphodiesterase inhibition or addition of 8-bromo-cyclic GMP, was accompanied by an increased ACE activity [20] . These findings indicate that NO and cyclic GMP modulate ACE expression / activity by different mechanisms.
Effect of ACE inhibition on eNOS and NO
The relative contribution of NO to the dilator response of BK and ACE inhibitors was shown in numerous investigations with isolated ischaemic rat hearts [21] [22] [23] and isolated intact blood vessels from different species including coronary microvessels and large arteries from the dog [24] , and microvessels from failing human hearts [25] . The significance of the endothelium in the action of BK and ACE inhibitors could be demonstrated in experiments in cultured endothelial cells from different sized vessels and different species [6, [26] [27] [28] . In these studies ACE inhibition like exogenously added BK led to an enhanced considered as an index for NO synthesis and release incubated for the times indicated with either TGF-b1 (1 ng / ml), the ACE [24, 29] .
inhibitor ramiprilat (100 nmol / l) or solvent. Thereafter, endothelial Recent data from our group revealed that ACE inhibiproteins were separated via gel electrophoresis and transferred to nitrotion not only stimulated NO synthesis but also induced the cellulose membranes. eNOS protein levels were detected and quantified with a specific monoclonal antibody and visualized by enhanced chemiexpression of eNOS. In primary cultured bovine aortic luminescence with a commercially available kit (Amersham). The auendothelial cells incubated for 36 h with the ACE inhibitor toradiographs were analyzed by scanning densitometry [19] . Values are ramiprilat, an approximately two-fold increase of eNOS means6SEM of six experiments performed on three different cell expression could be observed, which was sustained for at batches. * P,0.05 vs. the respective controls (100%). B: endothelial cells least 72 h of incubation (Fig. 1A) . This increase in eNOS were preincubated for 36 h with either TGF-b1 (1 ng / ml), ramiprilat (100 nmol / l) or solvent. After washing, NO-synthesis was induced by expression was accompanied by an enhanced production of incubation for 5 min with the calcium ionophore A23187 (1 mmol / l) and cyclic GMP after maximal stimulation with the calcium 28 assessed by intracellular cyclic GMP . Values are means6SEM of three ionophore A23187 (Fig.1B) . In comparison transforming experiments performed on three different cell batches. * P,0.05 vs.
growth factor-b1 (TGF-b1) which is known as 'standard' control (100%).
for induction of eNOS [30] led to a two to four-fold increase of eNOS expression after 36 and 72 h of incubation, respectively (Fig. 1A) , and in parallel to an ACE-resistant B kinin receptor agonist [35, 36] . The 2 increase of endothelial cyclic GMP production (Fig. 1B) . possibility of a direct interaction between ACE inhibitors and the B kinin receptor was supported by the finding that receptor antagonist icatibant [35, 37] . Similarily, ex vivo Studies with isolated porcine [31] , canine [32] , bovine data [38] showed that a 12 week long treatment with an and human coronary arteries [33, 34] enhanced the constrictor effect in the presence of an rilat enhanced H BK binding sites, blocked receptor desensitization and decreased receptor internalization inactivation of the extracellular regulated kinases Erk1 / 2 duced by high concentrations of BK analogues. However, [41] . These data, however, provided no direct biochemical none of these effects were observed in CHO cells transevidence for an ACE inhibitor-induced crosstalk between fected with B kinin receptor alone [39] [40] . Similar effects were observed
The heptapeptide angiotensin 1-7 (ANG 1-7) is rein native porcine endothelial cells where incubation with leased from ANG I or ANG II by various post-prolinethe ACE inhibitor ramiprilat either prior to, or following cleaving endopeptidases [43] (Fig. 2) . A marked rise in 3 BK stimulation decreased H BK binding to caveolin-rich plasma level of ANG 1-7 was observed in normotensive membranes, while increasing that in plasma membranes rats [44] [45] [46] and hypertensive patients [47] following ACE lacking the caveolin marker protein. This seemed to be blockade but also after treatment of normotensive and 3 distinct from enzyme inhibition, since H BK binding was hypertensive rats with a subtype AT ANG II receptor 1 not influenced in the presence of an inhibitory concenantagonist [45] . In contrast to the potent vasoconstrictor tration of a synthetic ACE substrate, which blocked the ANG II, ANG 1-7 has been reported to be a vasodilator degradation of BK [41] . Therefore, it was suggested that on endothelium-intact rat aorta [48] and coronary arteries ACE inhibitors stabilized the B kinin receptor in a Gof the pig [49] and dog [50] . However, ANG 1-7 alone 2 protein coupled or basally active form, thereby preventing had no effect on the tone of the isolated rabbit jugular vein, and or reversing its BK-induced sesquesteration to it significantly enhanced the constrictor response to BK in caveolae [42] prior to internalization. This effect of ACE a manner similar to the effect of ACE inhibitors [35] . inhibitors on B kinin receptors resulted in tyrosine Moreover, a recent report showed that in porcine coronary 2 phosphorylation, increase in intracellular calcium and arteries the vasodilator effect of ANG 1-7 only occurred when the B kinin receptor was desensitized by BK [51] . evidence for a physiological function of this subtype AT 2 2
Although a non-AT / non-AT subtype ANG II receptor receptor was shown for its axonal regeneration in the optic 1 2 with high affinity for ANG 1-7 in bovine aortic endothelinerve of adult rats [67] . However, all the effects of ANG II al cells was reported [52] many of its effects could not be cannot be ascribed to interaction with distinct ANG II explained by a specific receptor for the heptapeptide. Low receptor subtypes. NO production induced by Ang II was concentrations of ANG 1-7 potentiated the hypotensive prevented by subtype AT as well as AT ANG II receptor 1 2 action of BK in conscious normotensive rats [53] [54] [55] and blockers in coronary microvessels and large coronary facilitated the baroreceptor reflex in rats [56, 57] . Merely, arteries of the dog [60] . Ang II-induced endothelial kinin / Ferrario and co-workers reported that hypotension induced NO production favored an involvement of subtype AT 2 by ANG 1-7 alone in the absence of BK was only ANG II receptors, however this was challenged by the fact 1 observed in renin transgenic (TG ) rats [46] , SHR [58] , that one of 5 tested selective subtype AT ANG II receptor 1 and dogs with reno-vascular hypertension [59] . ANG 1-7-blockers behaved like a subtype AT ANG II receptor 2 induced vasodilation [35, 49, 50] and NO release from antagonist [63] . A possible explanation for this, could be microvessels and large arteries of the canine heart [60] was that slight conformational changes in the structure of the prevented by icatibant and the NO synthase inhibitor subtype AT ANG II receptor could convert subtype AT antagonists [60] . Furthermore, ANG 1-7 was shown to not interact with ACE, since ANG II was neither a inhibit purified canine ACE [61] (Fig. 2) .
substrate nor an inhibitor of ACE [62] (Fig. 2) . Some recent studies on pharmacological effects of ANG 1-7 showed that it was ineffective on B kinin receptors 2 that were transfected in CHO-cells. However, ANG 1-7 3. Pathophysiological relevance potentiated arachidonic acid release induced by a BK analogue when the cells were transfected with both the B 3. receptor site by binding to the active site of ACE, critical role in the maintenance of blood pressure homeoindependent of blocking BK hydrolysis [62] .
stasis [69, 70] . Treatment with eNOS inhibitors [71] [72] [73] and more recently, disruption of the gene encoding eNOS 2.5. ANG II and the kinin /NO system [74] , both significantly increased blood pressure in rats and mice, respectively. Shear stress as well as locally generated Like ANG 1-7, ANG II is able to activate the carcompounds such as BK, acetylcholine, ATP and substance diovascular kinin / NO system. In primary cultured bovine P were reported to be stimulators for endothelial NO endothelial cells ANG II concentration-dependently stimuproduction [6, 75] . Furthermore, it was suspected from lated cyclic GMP production and enhanced the release of experiments on isolated blood vessels [24, 34, 76, 77 ] that a endogenous kinins [63] . In these cells cyclic GMP biosignificant part of the blood pressure lowering effect of synthesis was blocked by icatibant as well as the NO ACE inhibitors in vivo was mediated by accumulation of synthase inhibitor L-NNA [64] . L-NNA as well as icatibant kinins. However, the antihypertensive effect of ACE also blocked the ANG II-induced production of NO, inhibitors could not be antagonized by icatibant in all assessed by nitrite release, in coronary microvessels and models of experimental hypertension [13] . The blood large coronary arteries of the dog [60] . The protection of pressure lowering effect of ACE inhibitors was only isolated rat hearts against postischaemic reperfusion inantagonized by icatibant in renovascular models of hyjuries in the presence of a subtype AT ANG II receptor pertension (aortic banding, two kidney one clip) with 1 210 blocker and a low (10 mol / l) concentration of ANG II increased plasma renin and ACE activity as well as ANG was abolished again by L-NNA and icatibant [65] . A recent II levels [13, [78] [79] [80] . Thus, it seemed that under these study showed a significantly enhanced cyclic GMP content conditions endogenously increased kinins might counteract in aortae of hypertensive rats during conditions of inthe vasoconstriction induced by high ANG II production. creased plasma ANG II concentrations from either ANG II In contrast, in kinin-deficient two kidney-one clip hyinfusion or increased biosynthesis of ANG II as a result of pertensive Brown Norway rats as well as in SHR, icatibant subtype AT ANG II receptor blockade [66] . This effect did not affect the hypotensive ACE inhibitor effect [81] .
1 was prevented by a subtype AT ANG II receptor antagoSimilarily, it was observed in patients with renal hyperten-2 nist as well as icatibant and L-NNA. Therefore, the authors sion that the blood pressure lowering effects of an ACE suggested that the increase in aortic cyclic GMP by inhibitor were more pronounced than in patients with elevated plasma ANG II was mediated by stimulation of primary hypertension [82] . In line with these data were subtype AT ANG II receptors resulting in a BK-depenrecent clinical observations in normotensive and hyperten-2 dent stimulation of aortic NO release. A further line of sive subjects where icatibant attenuated the blood pressure lowering effect of an ACE inhibitor. This effect of age were not always consistent (Table 1) . Furthermore icatibant tended to be greater in subjects with normal-to changes in eNOS expression seemed not to be conclusively high-plasma renin activity than in those with low plasma associated with respective changes in NO bioavailability. renin activity [83] . Furthermore, ACE inhibition enhanced Generally, in aortae of young pre-hypertensive and early flow-dependent endothelium-mediated dilation, 46% over hypertensive SHR eNOS expression / activity [89, 90] , basal baseline, in healthy normotensive humans by a BK-depenand stimulated aortic cyclic GMP content as well as the dent mechanism, whereas icatibant showed reduction of response to acetylcholine [93] were similar (if not en-33% [14] .
hanced) to that of age-matched WKY rats. With increasing Beside the activity of kinins, the bioavailability of NO age declined of eNOS expression [90] , basal and stimu-(NO synthesis minus NO decomposition by chemical lated cyclic GMP as well as impaired relaxation [93] and reactions) plays a major role in the regulation of blood decreased NO availability due to increased superoxide pressure (Fig. 2) . Chronic NO synthase inhibition induced formation was observed in senescent SHR [19] . a dose-dependent increase in blood pressure in normoten-
In animals with genetic hypertension subchronic inhibisive rats, which in turn was correlated with a decrease in tion of ACE improved endothelium-mediated dilation of arterial wall cyclic GMP content [84] . Furthermore, the the thoracic aorta [103, 104] and the mesenteric artery vasodilatory response to acetylcholine was impaired in [105] . Early-onset long-term treatment with ACE in-SHR when compared to normotensive Wistar Kyoto hibitors was shown to prevent the impairment of vasodilat-(WKY) rats [85, 86] . The basal NO dilator mechanism ion in spontaneously hypertensive stroke prone rats (SHRappeared to be abnormal in the forearm arterial bed of SP) independent of their antihypertensive action. This untreated patients with essential hypertension [87] . In such effect was accompanied by enhanced aortic cyclic GMP patients a diminished basal whole body NO production content [106] . was observed [88] . Therefore, alterations in NO expresIn a recent study we found in aortae of senescent SHR a sion / activity might be related to the pathogenesis of disarranged catalytic activity of eNOS which led to lower hypertension. Recent data revealed that depending on age, NO release and higher superoxide production. In these vascular bed and model of hypertension eNOS expression / animals early-onset long-term treatment with the ACE activity seemed to be differentially affected. However, data inhibitor ramipril preserved the normal arranged catalytic concerning the same tissue from rats of nearly the same activity of eNOS which resulted in increased NO pro- duction with concomitant decreased superoxide formation, attenuated intracellular calcium increase and NO release in one third of placebo levels [19] . The enhanced aortic NO bovine aortic endothelial cells [112] . In contrast other availability positively correlated with an increased eNOS investigators found an elevation of BK-induced intracelluexpression in carotid arteries [19] . A similar upregulation lar calcium by elevated cyclic AMP in the same tissue of eNOS was found in the heart of SHR-SP after lifelong [113, 114] . Furthermore, it was shown that increased treatment with ramipril [18] . An enhancement of eNOS endothelial cyclic AMP induced by forskolin amplified via was also observed in the atrial myocardium from patients activation of a cyclic AMP-dependent protein kinase the chronically treated with an ACE inhibitor [107] .
BK-induced synthesis of cyclic GMP [115] . With respect The mechanism by which ACE inhibition upregulated to the effect of cyclic AMP on the regulation of eNOS eNOS expression is still unclear. However, it is conceivexpression no direct data were available. However, it was able that ACE inhibitor-induced accumulation of endogenreported that elevated cyclic AMP activated gene transcripous kinins mediated this effect, since it was shown that the tion via binding to nuclear factor-1 (NF-1) [116] , which enhanced aortic cyclic GMP content after high and low was present in the promotor region of eNOS [117] . In line dose treatment with ramipril could be suppressed by with these observations we found that the strong cyclic cotreatment with icatibant [106] . Furthermore, in cultured AMP-elevating compound forskolin was able to upregulate bovine aortic endothelial cells incubated for 48 h with eNOS protein by about four-fold in cultured bovine aortic 8-bromo-cyclic GMP increased levels of cyclic GMP, endothelial cells. When compared to cyclic GMP the eNOS mRNA and protein were found [108] . We confirmed intracellular feedback regulation on eNOS expression by this cyclic GMP-mediated intracellular feedback mechacyclic AMP seemed to be more potent and rapid (Fig. 3) . nism in cultured bovine aortic endothelial cells, however, By contrast, in rat cardiac myocytes eNOS expression and only a weak upregulation of eNOS protein by 8-bromoactivity were markedly reduced by drugs that increased cyclic GMP occurred still after 72 h of incubation (Fig. 3) . intracellular cyclic AMP [118] . Moreover, data from the Another candidate contributing to the upregulation of same group suggested that even short term elevations in eNOS expression induced by ACE inhibition might be intracellular cyclic AMP may rapidly uncouple NO-depencyclic AMP (Fig. 2) . It is known that ACE inhibitors and dent signalling by inhibiting post-translational processing BK are able to enhance the turnover of endothelial of eNOS and its translocation to plasmalemmal caveolae in prostacyclin via an increased intracellular calcium cardiac myocytes [119] . [76, 109, 110] , which in turn stimulates the formation of cyclic AMP [111, 112] . However, divergent data have been 3.2. Atherosclerosis published about the functional role of endothelial cyclic AMP. It has been reported that enhanced cyclic AMP There is abundant evidence reported in the recent literature that the endothelial NO pathway is also involved in hypercholesterolaemia and atherosclerosis. Endothelium-dependent relaxations were reduced in rabbits on an atherogenic diet [120] [121] [122] . In agreement with these findings, chronic inhibition of eNOS impaired endothelial function and accelerated atherosclerosis in hypercholesterolaemic rabbits [123] . In patients with coronary atherosclerosis basal NO release was impaired as suggested by a blunted response by L-NNA [124] . Chronic adminstration of L-arginine improved endothelium-dependent relaxation in hypercholesterolaemic rabbits [121] and infusion of L-arginine restored endothelial dysfunction in the coronary microcirculation [125, 126] and forearm resistent vessels [127, 128] , of hypercholesterolaemic patients. Downregula- and NO release were markedly reduced [130] . The reduced Endothelial protein levels were separated via gel electrophoresis and transferred to nitrocellulose membranes. Expression of eNOS protein NO availability might be also due to an enhanced superoxlevels was detected and quantified using a specific monoclonal antibody ide production via endothelial xanthine oxidase activation and visualized by enhanced chemiluminescence with a commercially as observed in vessels of hypercholesterolaemic rabbits available kit (Amersham). The autoradiographs were analyzed by scan- [131] . It was found that eNOS dependent superoxide ning densitometry [19] . Values are means6SEM of six experiments production was enhanced in human endothelial cells performed on three different cell batches. * P,0.05 vs. the respective controls (100%). incubated with native low density lipoprotein (LDL) [132] .
It might be assumed, therefore, that native LDL uncouples release of kinins seemed to have cardioprotective actions [151, 155, 156] . When kinins were given locally in small L-arginine metabolism from NO release to increase eNOS-212 210 mediated generation of superoxide. amounts (10 to 10 mol / l) similar to physiological Improvement of endothelial function [133] [134] [135] [136] and blood concentrations, they prevented ischaemia-induced morphology [137, 138] by ACE inhibitors was demondamages in the heart [13, 157] . Drugs that inhibited breakstrated in experimental models of hypercholesterolaemia down of kinins induced a similar pattern of beneficial and atherosclerosis. However, the mechanism by which effects [13, 157] . Drugs that blocked kinin receptors during ACE inhibitors affect atherosclerosis is not well underischaemia reversed the beneficial cardioprotective effects stood. Reduction of ANG II production should play a role, evoked by BK or ACE inhibitors [13, 157] . In addition, since ANG II among others was able to stimulate the kinins seemed to contribute to the immediate [158, 159] , production of superoxide via NAD(P)H oxidases mainly in and delayed [160] cardioprotective effects associated with vascular smooth muscles [139] . Additionally, an increased ischaemic preconditioning. The enhanced release of kinins ACE immunoreactivity and increased concentrations of from ischaemic myocardial tissue was always correlated immunoreactive ANG II were found within atherosclerotic with an increase of NO [21, 161] . In hearts of patients with plaques of human coronary artery segments [140] . ACE effort angina NO production increased by provocation of not only generates ANG II, but also inactivates kinins.
myocardial ischaemia induced by exercise stress [162] . Inhibition of kinin breakdown by ACE inhibitors enhanced synthesis and release of NO, which had an antiproliferative 3.4. Myocardial infarction-remodeling influence on vascular smooth muscle cells [141, 142] . Vascular protection by ACE inhibition via activation of the There was also direct evidence for a major role of kinin / NO pathway was supported by recent findings which endothelium-derived NO in controlling vascular smooth showed that the acute toxic effects of oxidized LDL were muscle proliferation in response to remodeling stimulus. attenuated in isolated aortae from chronically ACE inhibAfter carotid artery ligation mice with targeted disruption itor treated rats [143] . Furthermore, these effects were of their eNOS gene did not show a remodeling of their prevented by icatibant and L-NNA. In apolipoprotein (apo) common ipsilateral carotid arteries, whereas wild-type E-deficient mice treated for 12 weeks with the ACE mice did [163] . Abnormalities of vasomotor tone were inhibitor captopril the resulting reduced aortic lesions were characteristic of heart failure. Impaired cyclic GMP-mecorrelated with a strong inhibition of LDL oxidation [144] . diated relaxations of the pulmonary artery and thoracic In the same model inhibition of LDL oxidation was also aorta were observed in rats 12 weeks after myocardial observed with the ACE inhibitor fosinopril lacking a infarction [164] . However, impairment in endotheliumsulfhydryl group [145] . Thus ACE inhibition seemed to dependent relaxation was not uniform throughout the reduce LDL oxidation by scavenging superoxide through vasculature. Pulmonary arteries appeared to be more enhanced NO synthesis and release. In this context it is impaired than systemic arteries or mesenteric artery resistinteresting that long-term ACE inhibition in SHR preance vessels in rats 10 weeks after myocardial infarction vented the development of a disarranged catalytic activity [165] . In a rat model of chronic heart failure (normotensive of eNOS, which was characterized by high superoxide rats with myocardial infarction), early and delayed ACE production, and thereby, preserved a normal arranged inhibitor treatment both increased survival and exerted eNOS activity with higher NO-bioavailability and lower similar beneficial effects on cardiac hemodynamics and superoxide production [19] . In line with these findings the remodeling [166] , an effect which was also observed in TREND study [146] revealed that six month ACE inhibitor patients [167] . Similar findings including lifespan extentreatment of normotensive patients with documented sion were obtained in hypertensive rats after lifelong atherosclerosis (without severe lipidaemia or evidence of treatment with ramipril [18] but also when a late treatment heart failure) improved endothelial dysfunction.
was started in 15 month old animals [168] . In both treatment regimens an upregulation of vascular [18] and 3.3. Myocardial ischaemia cardiac eNOS expression / activity was found [168] . Interestingly, cardiac cyclic GMP and nitrate / nitrite content It was demonstrated that ACE inhibitors reduced were less in SHR than in WKY rats. Chronic L-arginine myocardial injury in cell culture [147] , in isolated hearts administration increased these levels only in SHR, sug- [21] , and in intact animal models [148, 149] . These effects gesting enhanced NO production was accompanied by an were not only due to a decreased synthesis of ANG II, but attenuation of cardiac hypertrophy in these animals [101] . also due to the demonstrated ability of these drugs to Recently, in vitro studies with cultured cardiomyocytes attenuate the degradation of endogenous kinins in the heart revealed that the antihypertrophic effect of BK was [150] [151] [152] for which a local kallikrein-kinin system was critically dependent on endothelium-derived NO. Only described [153, 154] . That kinins play a significant role in when cardiomyocytes were cocultured with endothelial myocardial ischaemia was supported by many investigacells, BK was able to abolish the hypertrophic effect tions. In the ischaemic heart the enhanced generation and induced by ANG II [169] .
Furthermore, it was found in a chronic model of heart eNOS activity. Therefore, the regulation of eNOS is failure induced by myocardial infarction in rats that ACE relevant in the development of hypertension, atheroscleroinhibition acting via kinins had an antitrophic and an sis and heart failure, where impaired endothelium-derived improved cardiodynamic effect. The ACE inhibitor-in-NO is observed. Both, kinins and ACE inhibitors are able duced decrease of ventricular volume, myocyte size, and to upregulate eNOS protein and to enhance NO prointerstitial fibrosis [170] as well as myocardial function duction. Furthermore, kinins and ACE inhibitors are able [171] were partially blocked by icatibant. Moreover, the to reduce superoxide production, generated by a dysfuncbeneficial effects of ACE inhibition on left ventricular tional eNOS (Fig. 2) . hypertrophy in rats with hypertension caused by aortic
In addition to these interactions, effects on the ANG 1-7 banding as well as on infarct-induced heart failure in as well as subtype AT ANG II receptor level, or via direct 2 normotensive rats were prevented by specific B kinin effects of ACE inhibitors on the B kinin receptor might 2 2 receptor blockade [172, 173] . Similar antiproliferative efbe important in the crosstalk among ACE, kinins and NO fects were observed under subtype AT ANG II receptor (Fig. 2 cause a negative inotropic effect in myocytes [180] , which The basal and stimulated activity of endothelium-de- is an inverse relationship between the expression / activity
Conclusion
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